Our Faculty

Education

Pharmacy Practice Residency, Specialty in Ambulatory Care; Boston VA Medical Center
PharmD, Massachusetts College of Pharmacy and Health Sciences, 1996
BS, Pharmacy, Massachusetts College of Pharmacy and Health Sciences, 1990

Professional Licensure/Certification

Registered Pharmacist (RPh), Certified Diabetes Educator (CDE), Board Certified in Advanced Diabetes Managment (BC-ADM)

Areas of Teaching

• Diabetes
• Cardiovascular disease
• Women's Health
• Over-the-Counter drugs

Scholarly Interests

• Diabetes
• Cardiovascular disease
• Scholarship of teaching

Peer-Reviewed Articles & Book Chapters

• Edwards KL, Riche DM, Stroup JS, Goldman-Levine JD, Padiyara RS, Cross LB, Kane MP. Insulin glargine and cancer risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy: 2010;30(9):955-965.
• Goldman-Levine JD. Beyond metformin; initiating combination therapy in patients with type 2 diabetes.  Pharmacotherapy. 2011;31(12 pt 2): 44S-53S.
• Goldman-Levine JD, Insulin Pen Doses. Expert Questions and Answers. Diabetes Self Management: 2009:Sept/Oct:55-56.
• Cheng J, Bhatt S, Goldman-Levine JD, The benefit and risk of antidiabetic agents used in patients with heart disease. Journal of Pharmacy Practice, published online November 2008, publication in print March/April issue, 2009:22;(2):179-193.
• Goldman-Levine JD. Zoledronic acid for osteoporosis. American Family Physician: 2008 :78(4):508-509.
• Pareira CE, Goldman-Levine JD. Case Report, letter: Venlafaxine extended release induced alopecia. Annals of Pharmacotherapy:2007;41:1084.
• Goldman-Levine JD. Insulin detemir for diabetes mellitus. American Family Physician: 2006;74(2):323-324.
• Goldman-Levine JD, Bohlman LG. Ezetimibe/Simvastatin for cholesterol. American Family Physician: 2005;72(10):2081-2082.
• Goldman-Levine JD, Lee KW. Insulin Detemir-A New Basal Insulin Analog. The Annals of Pharmacotherapy: 2005;39(3):502-7.
• Lemieux A, Goldman-Levine JD, Gorren J. Aripiprizole: An antipsychotic with a novel mechanism of action. J Pharm Technol 2003;19:365-72.
• Bechara C, Goldman-Levine JD. Case Report: Dramatic worsening of type 2 diabetes mellitus due to olanzapine after 3 years of therapy. Pharmacotherapy 2001;21(11):1444-1447.

Honors

• Pharmacy Practice Teacher of the Year, MCPHS
• Trustees Award for Teaching Excellence, MCPHS
• Recognition of teaching in Family Medicine, AAFP American Academy of Family Physicians
• Preceptor of the Year Given by the office of experiential education, MCPHS
• Long-Term Faculty Service Award, MCPHS
• Fellow, American College of Clinical Pharmacy
  
  

Current Professional Memberships, Service & Leadership

• Academic Reviewer for "Pharmacotherapy" The Journal of Human Pharmacology and Drug Therapy
• Expert Peer Review Panel for "American Academy of Diabetes Educators" (AADE)
• Academic Peer Reviewer for "American Journal of Lifestyle Medicine"
• Academic Peer Reviewer for "Annals of Family Medicine"
• "Prescribers Letter/Pharmacists Letter" Specialty Consultant Panel (area of diabetes)
• Phi Lambda Sigma Leadership Fraternity, MCPHS
• RHO CHI Pharmacy Honor Society, PSI Chapter, MCPHS
• Nonprescription Medicines Academy (NMA)
• Endocrine PRN group of ACCP
• Diabetes Educators of Eastern Massachusetts (DEEM)
• American Association of Diabetes Educators (AADE)
• American Association of Diabetes Educators Specialty Practice Group (AADE-SPG)
• American Association of Colleges of Pharmacy (AACP)
• Ambulatory Care PRN group of ACCP American College of Clinical Pharmacy (ACCP)
• American Society of Health System Pharmacists (ASHP)
• Member, Diabetes Guidelines Work Group, Diabetes Prevention and Control Program: Massachussetts Guidelines for Adult
• Diabetes Care, 2007, 2009
• Massachusetts Pharmacists Association (MPHA)
• Massachusetts Association of Health System Pharmacists (MSHP)
• New England Institute of Ambulatory Care Pharmacists (NEIAP)